Poje, G., Marinović, M., Pavić, K., Mioč, M., Kralj, M., Pessanha de Carvalho, L., Held, J., Perković, I. & Rajić, Z. (2022) Harmicens, Novel Harmine and Ferrocene Hybrids: Design, Synthesis and Biological Activity. International journal of molecular sciences, 23, 9315, 20 doi:10.3390/ijms23169315.

doiwww.mdpi.comdoi.orgfulir.irb.hr

Mioč, M., Telbisz, Á., Radman, K., Bertoša, B., Šumanovac, T., Sarkadi, B. & Kralj, M. (2022) Interaction of crown ethers with the ABCG2 transporter and their implication for multidrug resistance reversal. Histochemistry and cell biology, 158, 261-277 doi:10.1007/s00418-022-02106-z.

doi

Beč, A., Mioč, M., Bertoša, B., Kos, M., Debogović, P., Kralj, M., Starčević, K. & Hranjec, M. (2022) Design, synthesis, biological evaluation and QSAR analysis of novel N-substituted benzimidazole derived carboxamides. Journal of enzyme inhibition and medicinal chemistry, 37 (1), 1327-1339 doi:10.1080/14756366.2022.2070910.

doiwww.tandfonline.comdx.doi.org

Lončar, B., Perin, N., Mioč, M., Boček, I., Grgić, L., Kralj, M., Tomić, S., Radić Stojković, M. & Hranjec, M. (2021) Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study. European journal of medicinal chemistry, 217, 113342, 18 doi:10.1016/j.ejmech.2021.113342.

doi

Meščić Macan, A., Perin, N., Jakopec, S., Mioč, M., Radić Stojković, M., Kralj, M., Hranjec, M. & Raić-Malić, S. (2020) Synthesis, antiproliferative activity and DNA/RNA-binding properties of mono- and bis-(1,2,3-triazolyl)-appended benzimidazo[1,2-a]quinoline derivatives. European journal of medicinal chemistry, 185, 111845, 11 doi:10.1016/j.ejmech.2019.111845.

doi

Cindrić, M., Sović, I., Mioč, M., Hok, L., Boček, I., Roškarić, P., Butković, K., Martin-Kleiner, I., Starčević, K., Vianello, R., Kralj, M. & Hranjec, M. (2019) Experimental and computational study of the antioxidative potential of novel nitro and amino substituted benzimidazole/benzothiazole-2-carboxamides with antiproliferative activity. Antioxidants, 8 (10), 477, 22 doi:10.3390/antiox8100477.

doidx.doi.orgwww.mdpi.comfulir.irb.hr

Guberović, I., Marjanović, M., Mioč, M., Ester, K., Martin-Kleiner, I., Šumanovac Ramljak, T., Mlinarić-Majerski, K. & Kralj, M. (2018) Crown ethers reverse P-glycoprotein-mediated multidrug resistance in cancer cells. Scientific Reports, 8 (1), 14467, 14 doi:10.1038/s41598-018-32770-y.

doiwww.nature.comfulir.irb.hr

Mioč, M. (2022) 'Povećanje osjetljivosti tumorskih stanica na terapiju modulacijom aktivnosti transportera ABCB1 i ABCG2 diaza krunastim eterima i derivatima primakina', doktorska disertacija, Poslijediplomski interdisciplinarni sveučilišni studij Molekularne Bioznanosti, Osijek.

mobi.unios.hr